Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Cancer. 2010 Aug 16;116(23):5470–5478. doi: 10.1002/cncr.25518

Figure 1.

Figure 1

Tumor absorbed dose versus mass is shown. Tumor absorbed dose was determined after infusion of high-activity samarium-153 ethylenediamine tetramethylene phosphoric acid and compared with tumor mass on a lesion-by-lesion basis for 16 individual tumors from 7 subjects. No correlation was seen (R2 = 0.11, P = .208). Gy indicates grays.